In an in vivo model of cancer cachexia, EPA supplementation decreased the expression of zinc-α2-glycoprotein (ZAG), a lipolytic factor, in white and brown adipose tissue [114], demonstrating another mechanism of action related to EPA supplementation in cachexia. This evidence concerns the gene AZGP1 and cancer.